(HealthDay)—The U.S. Food and Drug Administration has approved the first device to treat dialysis-related amyloidosis (DRA), a complication of dialysis used to treat kidney failure.
Mar 6, 2015
0
7
A surgical procedure that was virtually abandoned in the 1950s because of its high mortality rates in trying to save patients with acute pulmonary embolism may actually prevent more deaths in severely ill patients than current ...
Feb 10, 2015
0
4
(HealthDay)—A new technology designed to reduce stroke risk in certain patients has been approved by the U.S. Food and Drug Administration, the agency announced Monday.
Feb 9, 2015
0
5
In a study to be presented on Feb. 6 in an oral concurrent session at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will present findings on a study of mothers ...
Feb 2, 2015
0
4
A new study of more than 3,000 women confirms that low birthweight predicts an increased risk of type 2 diabetes in adulthood and reports which intermediating biomarkers appear to be the best predictors. The research could ...
Jan 5, 2015
0
45
Good news for people who are already following a diet rich in fruits, vegetables and whole grains, and low in sweets: New research suggests these heart-healthy eaters don't need to worry about choosing low glycemic index ...
Dec 16, 2014
9
1
For up to one in five Americans over age 65, getting older brings memory and thinking problems- along with the embarrassment of not being as "sharp" as they once were, and the worry that it will get much worse.
Dec 16, 2014
0
0
Two studies published in the January issue of Anesthesiology, the official medical journal of the American Society of Anesthesiologists (ASA), shed new light on the prevalence of transfusion-related acute lung injury (TRALI) ...
Dec 16, 2014
0
0
Leptin, a hormone that regulates the amount of fat stored in the body, also drives the increase in blood pressure that occurs with weight gain, according to researchers from Monash University and the University of Cambridge.
Dec 4, 2014
0
0
(HealthDay)—Blincyto (blinatumomab) has been approved by the U.S. Food and Drug Administration to treat Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia, a rare cancer of the bone marrow.
Dec 3, 2014
0
0
